webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

DACN(Ms,Ns)

  CAS No.: 2411082-25-0   Cat No.: BADC-01781 4.5  

DACN(Ms,Ns) is a disulfide ADC linker reagent bearing mesylate and nosylate leaving groups, designed to improve conjugation efficiency and controlled payload release in antibody-drug conjugates. Keywords: ADC linker, disulfide linker, cleavable linker, mesylate linker.

DACN(Ms,Ns)

Structure of 2411082-25-0

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C14H17N3O6S2
Molecular Weight
387.43

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
1-methylsulfonyl-5-(2-nitrophenyl)sulfonyl-1,5-diazacyclonon-7-yne
Canonical SMILES
CS(=O)(=O)N1CCCN(CC#CC1)S(=O)(=O)C2=CC=CC=C2[N+](=O)[O-]
InChI
InChI=1S/C14H17N3O6S2/c1-24(20,21)15-9-4-5-10-16(12-6-11-15)25(22,23)14-8-3-2-7-13(14)17(18)19/h2-3,7-8H,6,9-12H2,1H3
InChIKey
YDKDZBPRKZPTLJ-UHFFFAOYSA-N

DACN (Ms Ns) is an abbreviation representing a class of modified nucleotides utilized in diverse biotechnological contexts. Here are four key applications of DACN (Ms Ns):

Nucleic Acid Amplification: In the realm of nucleic acid amplification, DACNs play a pivotal role in techniques like polymerase chain reactions (PCR), heightening both specificity and yield. Through the integration of these modified nucleotides, the precision of DNA replication is enhanced by reducing mismatches during amplification. Researchers rely on DACNs to uphold heightened fidelity in applications such as cloning, sequencing, and genetic analysis, ensuring the accuracy and integrity of genetic information propagation.

Diagnostic Assays: Within diagnostic assays, DACNs contribute to augmented sensitivity and specificity in the detection of pathogens and genetic markers. By incorporating DACNs into probes and primers, diagnostic tests achieve heightened reliability in identifying infections or genetic irregularities. This application holds particular significance in the realm of early disease detection and personalized medicine, empowering healthcare professionals to deliver tailored and precise medical interventions.

Therapeutic Development: The arena of therapeutic development benefits significantly from the incorporation of DACNs in the design of therapeutic oligonucleotides, like antisense molecules and siRNAs. These modified nucleotides bolster the stability and binding affinity of therapeutic agents, thereby enhancing their efficacy in silencing target genes. This innovative approach shows promise in combating a spectrum of genetic and viral diseases, including cancer and hepatitis, providing renewed hope for patients seeking effective treatment options.

Synthetic Biology: Within the domain of synthetic biology, DACNs serve as key components in the construction of artificial genetic circuits and pathways. These modified nucleotides are integrated into synthetic genes and regulatory elements to finely regulate their expression and interactions. This sophisticated manipulation enables the creation of engineered organisms with tailored characteristics, facilitating advancements in diverse applications ranging from biofuel production to environmental cleanup efforts.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: N3-L-Dab(Fmoc)-OH | Norbornene-NHS | Norbornene-methyl-NHS | Boc-Ser(O-propargyl)-OH (DCHA) | Doxorubicin hydrochloride | CL2A-SN-38 DCA | DACN(Tos2,6-OH) | DACN(Ms) hydrochloride | DACN(Tos) hydrochloride | DACN(Tos,Ns) | DACN(Ms,Ns)
Send Inquiry
Verification code
Inquiry Basket